Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-17-001526
Filing Date
2017-08-01
Accepted
2017-08-01 11:23:45
Documents
2
Period of Report
2017-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K oncolyticsform6k.htm 6-K 16437
2 NEWS RELEASE DATED AUGUST 1, 2017 ex991.htm EX-99.1 5962
  Complete submission text file 0001279569-17-001526.txt   23410
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 17995580
SIC: 2834 Pharmaceutical Preparations